Cargando…

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP (Swe) /PS1ΔE9 Transgenic Female Mice

Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses therapeutic-like...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coles, Madilyn, Watt, Georgia, Kreilaus, Fabian, Karl, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789874/ https://www.ncbi.nlm.nih.gov/pubmed/33424597 http://dx.doi.org/10.3389/fphar.2020.587604

Ejemplares similares

Longitudinal investigation of neuroinflammation and metabolite profiles in the APP (swe)×PS1(Δe9) transgenic mouse model of Alzheimer's disease
por: Chaney, Aisling, et al.
Publicado: (2017)

Evodiamine derivatives improve cognitive abilities in APP(swe)/PS1(ΔE9) transgenic mouse models of Alzheimer's disease
por: Pang, Shuo, et al.
Publicado: (2020)

Microglia Express Insulin-Like Growth Factor-1 in the Hippocampus of Aged APP(swe)/PS1(ΔE9) Transgenic Mice
por: Myhre, Christa Løth, et al.
Publicado: (2019)

The Lack of Amyloidogenic Activity Is Persistent in Old WT and APP(swe)/PS1ΔE9 Mouse Retinae
por: Joly, Sandrine, et al.
Publicado: (2021)

Cortical iron regulation and inflammatory response in Alzheimer's disease and APP(SWE)/PS1(ΔE9) mice: a histological perspective
por: Meadowcroft, Mark D., et al.
Publicado: (2015)

Behavioural Phenotyping of APP(swe)/PS1(δE9) Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment
por: Olesen, Louise Ørum, et al.
Publicado: (2016)

Deletion of the type-1 interferon receptor in APP(SWE)/PS1(ΔE9) mice preserves cognitive function and alters glial phenotype
por: Minter, Myles R., et al.
Publicado: (2016)

Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APP(SWE)/PS1(ΔE9) Transgenic Mice Implicate Cathepsin Z in Alzheimer’s Disease
por: Thygesen, Camilla, et al.
Publicado: (2018)

APP(swe) /PS1(ΔE9) mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease
por: Wang, Manli, et al.
Publicado: (2023)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice
por: Naert, Gaëlle, et al.
Publicado: (2012)

Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP(SWE)/PS1(ΔE9) murine model of Alzheimer’s disease
por: Minter, Myles R., et al.
Publicado: (2017)

Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ(9)-tetrahydrocannabinol
por: Kanyo, Richard, et al.
Publicado: (2021)

Effect of genotype and age on cerebral [(18)F]FDG uptake varies between transgenic APP(Swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer’s disease
por: Snellman, Anniina, et al.
Publicado: (2019)

Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice
por: Wang, Sheng, et al.
Publicado: (2019)

Age- and brain region-associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPP(SWE)/PS1(ΔE9) transgenic mice using arterial spin labeling
por: Guo, Yapei, et al.
Publicado: (2019)

Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APP(swe)/PS1(dE9) Mice and Their Wild Type Littermates
por: Zhang, Feng, et al.
Publicado: (2018)

Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
por: Faizi, Mehrdad, et al.
Publicado: (2012)

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APP(swe) Alzheimer’s Disease Mouse Model
por: Zamarbide, Marta, et al.
Publicado: (2022)

Early Enriched Environment Exposure Protects Spatial Memory and Accelerates Amyloid Plaque Formation in APP(Swe)/PS1(L166P) Mice
por: Montarolo, Francesca, et al.
Publicado: (2013)

Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP(Swe) Mouse Models of Tauopathy and Amyloidosis
por: Briggs, Denise Isabelle, et al.
Publicado: (2017)

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017)

20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis
por: Lin, Kaili, et al.
Publicado: (2021)

Active constituent of Polygala tenuifolia attenuates cognitive deficits by rescuing hippocampal neurogenesis in APP/PS1 transgenic mice
por: Wang, Xiao-feng, et al.
Publicado: (2021)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice
por: O’Neal-Moffitt, G., et al.
Publicado: (2015)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APP(Swe)/PSEN1(M146V) transgenic mice
por: Medawar, Evelyn, et al.
Publicado: (2018)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
por: Reale, Marcella, et al.
Publicado: (2018)

Altered membrane properties but unchanged intrinsic excitability and spontaneous postsynaptic currents in an aged APP(swe)/PS1dE9 model of Alzheimer’s disease
por: Ohline, Shane M., et al.
Publicado: (2022)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
por: Geng, Pengcheng, et al.
Publicado: (2018)

DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss
por: Zhou, Wei, et al.
Publicado: (2019)

27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction
por: Wang, Ying, et al.
Publicado: (2020)

Reliability of the DSS-Swe Questionnaire
por: Jans, Anders, et al.
Publicado: (2023)

A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APP(SweDI) Mice
por: Jansone, Baiba, et al.
Publicado: (2015)

Continuous-Flow Synthesis of Δ(9)-Tetrahydrocannabinol and Δ(8)-Tetrahydrocannabinol from Cannabidiol
por: Bassetti, Benedetta, et al.
Publicado: (2023)

Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice
por: Luo, Min, et al.
Publicado: (2021)

Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019)

A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APP(Swe)/PSEN1(ΔE9) Mice Model of Amyloid Pathology
por: Tautou, Marie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ldhkaiaf84igo3ehib0fvr5hee